Search for a doctor

Scott H. Kaufmann, M.D., Ph.D.

  1. Internist
  2. Oncologist
  3. Chair, Molecular Pharmacology and Experimental Therapeutics, Minnesota
Request an Appointment

Departments

Location

  1. Rochester, Minnesota

Languages

English

Existing patients

  1. Acute leukemia
  2. Ovarian cancer
  • Biology and therapy of ovarian cancer and acute leukemia
  1. 1987
    Clinical Fellowship - OncologyThe Johns Hopkins University School of Medicine
  2. 1986
    Research Fellowship - Oncology Research Fellow, Oncology CenterThe Johns Hopkins University School of Medicine
  3. 1985
    Internship/Residency - Department of MedicineJohns Hopkins University School of Medicine and Hospital, The Johns Hopkins University
  4. 1981
    PhD - Department of Pharmacology and Molecular SciencesThe Johns Hopkins University School of Medicine
  5. 1981
    MDThe Johns Hopkins University School of Medicine
  6. 1975
    BA - ChemistryCarleton College

Certifications

  1. 1989
    Medical OncologyAmerican Board of Internal Medicine
  2. 1987
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2011
    Moelecular Pharmacology and Experimental Therapeutics Teacher of the YearMayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic College of Medicine and Science, Department of Education Administration
  2. 2010
    Society of ScholarsJohns Hopkins University Alumni Association
  3. 2007
    Molecular Pharmacology and Experimental Therapeutics Teacher of the YearMayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic College of Medicine and Science, Department of Education Administration
  4. 1998
    Stohlman ScholarLeukemia Society
  5. 1993
    Leukemia Society of America ScholarLeukemia Society
  6. 1989
    Clinical Oncology Career Development AwardAmerican Cancer Society
  7. 1987
    Clinician Scientist AwardMerck & Co., Inc.
  8. 1982
    Alpha Omega AlphaAlpha Omega Alpha Honor Medical Society
  9. 1982
    Sandoz AwardAwarding Organization
  10. 1975
    MemberSigma Xi, The Scientific Research Society
  11. 1974
    MemberPhi Beta Kappa Honor Society
  12. 1971
    Presidential ScholarAwarding Organization

Professional memberships

  1. 2018 - present
    Association of American Physicians
  2. 2015 - present
    Center Director's External Advisory Board, Moffitt Cancer Center Myeloma SPORE
  3. 2015 - present
    Search Committee, Department of Pharmacology
  4. 2015
    Mayo Clinic Taskforce on Research Centers
  5. 2015
    Mayo Clinic Taskforce on Research Centers
  6. 2015 - 2016
    Reseach Physician/Scientist Compensation Task Force
  7. 2014 - 2015
    VX-970 Project Team Member, Early Trials Clinical Trials Network, Cancer Treatment Evaluation Program, NCI
  8. 2014 - present
    Mayo Clinic Breast SPORE Executive Committee
  9. 2014 - present
    External Advisory Board, M.D. Anderson Cancer Center Ovarian SPORE
  10. 2014 - present
    Abbvie PARP Inhibitor Correlative Studies Planning Committee
  11. 2014
    Nominating Committee for Officers and Councilors, Mayo Clinic Rochester Committees
  12. 2014
    2014 Team Science Task Force
  13. 2013 - present
    External Advisory Board, Moffitt Cancer Center Myeloma SPORE
  14. 2013 - 2014
    Mayo Clinic Discovery Science Taskforce
  15. 2013
    Clovis ARIEL2 Planning Committee
  16. 2012 - present
    External Advisory Board, Roswell Park Cancer Institute Experimental Therapeutics Program
  17. 2012 - 2013
    Search Committee, Research Committee, Department of Oncology
  18. 2012 - 2013
    Systems Pharmacology Search Committee
  19. 2012
    Executive Dean for Research Search Committee
  20. 2012 - 2013
    Pharmacoepigenomics Search Committee, Center for Individualized Medicine
  21. 2012 - 2013
    Pharmacoepigenomics Search Committee, Center for Individualized Medicine
  22. 2012 - present
    Research Core Oversight Subcommittee, Mayo Clinic Research Committee, Mayo Clinic Committees
  23. 2012 - present
    American Society for Pharmacology and Experimental Therapeutics
  24. 2011 - present
    Mayo Clinic Cancer Center Inter-SPORE Advisory Committee
  25. 2010
    Merck SCH90776 Chk1 Inhibitor Advisory Board
  26. 2010 - 2014
    Mayo Clinic Breast SPORE Internal Advisory Committee
  27. 2010 - 2012
    Relentless for a Cure Selection Committee, Leukemia & Lymphoma Society Minnesota Chapter
  28. 2009
    Division of Hematology Education Subcommittee for the Development of the Hematology/Oncology 2nd Year Research Block, Hematology Research Committee, Mayo Clinic Cancer Center Committees
  29. 2009 - present
    American Society for Hematology
  30. 2009 - present
    Europena Research Institute for Integrated Cellular Pathology
  31. 2008 - 2013
    DNA Repair and Apoptosis Task Force, Investigational Drug Steering Committee, National Cancer Institute
  32. 2008
    2008 Schulz Symposium on Novel Therapeutics
  33. 2008 - present
    Cancer Molecular Therapeutics Research Association
  34. 2007 - 2010
    Oversight Committee for Flow Cytometry and Optical Morphology Shared Resource, Cancer Center Oversight Committee, Mayo Clinic Cancer Center Committees
  35. 2007 - 2008
    X-ray Crystallography Search Committee, Department of Medicinal Chemistry, University of Minnesota
  36. 2006
    AstraZeneca Emerging Oncology Clinical and Translational Strategy Group
  37. 2006 - present
    External Advisory Board, Moffitt Cancer Experimental Therapeutics Program
  38. 2006 - 2008
    Search Committee, Research Committee, Department of Oncology
  39. 2006 - 2007
    Office of Sponsored Projects Advisory Committee, Mayo Foundation for Medical Education and Research
  40. 2005 - present
    Director's Internal Scientific Advisory Committee, Mayo Clinic Cancer Center Committees, Mayo Clinic Cancer Center
  41. 2004 - 2005
    American Association for Cancer Research
  42. 2004 - 2005
    American Association for Cancer Research
  43. 2004 - present
    K12 Program Steering Committee, Division of Oncology Research, Department of Oncology
  44. 2003 - 2004
    Education Committee, American Association for Cancer Research
  45. 2003 - present
    M.D.-Ph.D. Program Committee, Mayo Clinic Education Committee, Mayo Clinic Committees
  46. 2003 - present
    Developmental Therapeutics Program, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  47. 2001 - 2006
    ACCR Workshop "Molecular Biology in Clinical Oncology"
  48. 2000 - 2001
    Scientific Advisory Board, 4th International Symposium on Leukemia and Lymphoma: Molecular Pharmacology and New Treatment Modalities
  49. 2000 - 2001
    Organizing Committee, AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics, American Association for Cancer Research
  50. 2000
    External Review Committee, Picower Institute, Manhassett, New York
  51. 2000 - present
    Executive Committee, M.D.-Ph.D. Program Committee, Mayo Clinic Education Committee
  52. 1999 - 2000
    Program Committee, Drug Resistance Subcommittee, American Association for Cancer Research
  53. 1999 - 2000
    Bayer Pharmaceuticals Oncology Advisory Board
  54. 1999 - 2001
    Drug Resistance Subcommittee, American Association for Cancer Research
  55. 1999 - 2011
    Novel Therapeutics Committee, North Central Cancer Treatment Group
  56. 1999 - 2011
    Novel Therapeutics Committee, North Central Cancer Treatment Group
  57. 1999 - 2000
    Annual Research Forum Organizing Committee, Mayo Clinic Committees
  58. 1998 - 2004
    External Advisory Committee, "Mechanisms of Drug Resistance in Hematological Malignancies." P01 CA82533 (W. Dalton, PI)
  59. 1998 - 2000
    Search Committee, Research Committee, Department of Oncology
  60. 1998 - 1999
    Organizing Committee, Special Conference on Molecular Determinants of Sensitivity to Antitumor Agents, American Association for Cancer Research
  61. 1997
    Gordon Conference on Chemotherapy of Experimental and Clinical Cancer
  62. 1997 - 1998
    Tumor Immunologist Search Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  63. 1996
    Gordon Conference on Chemotherapy of Experimental and Clinical Cancer
  64. 1996 - present
    External Advisory Committee, "Modulation of Apoptosis to Improve Cancer Therapy." P01 CA25842 (D. Martin)
  65. 1996 - 2003
    Internal advisory committee, "Studies on Monoclonal Gammopathies." P01 CA62242 (R. Kyle)
  66. 1996 - 1999
    Hematology Research Committee, Division of Hematology, Department of Internal Medicine
  67. 1996 - 1999
    Director's Advisory Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  68. 1996 - 1997
    Incyte Task Force, Mayo Clinic Task Forces/Work Groups
  69. 1995 - 1996
    Radiobiologist Search Committee, Department of Oncology
  70. 1995 - present
    M.D.-Ph.D. Program Committee, Mayo Clinic Education Committee, Mayo Clinic Committees
  71. 1994 - 1995
    Protocol Concept Review Committee, Department of Oncology
  72. 1994 - 1999
    Translational Research Committee, North Central Cancer Treatment Group, Mayo Clinic Cancer Center - Rochester
  73. 1994 - 1995
    Research Review Committee, Department of Oncology
  74. 1991 - present
    American Association for the Advancement of Science
  75. 1990 - present
    American Association for Cancer Research
  76. 1988 - 1991
    The Endocrine Society
  77. 1988 - present
    American Society for Cell Biology
  78. 1987 - present
    Eastern Cooperative Oncology Group

Publications

Research activities

See a description of research activities.